Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Oberbauer

Showing results (251-260 of 291) with videos related to

Pageof 30
Sort By:
Transplantation|April 28, 2016
Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening StudyFarsad Eskandary, Gregor Bond, Nicolas Kozakowski, et al.
Frontiers in Immunology|October 21, 2022
Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipientsBilgin Osmanodja, Johannes Stegbauer, Marta Kantauskaite, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 30, 2021
Organ transplants of the future: planning for innovations including xenotransplantationEmanuele Cozzi, Stefan Schneeberger, Maria Irene Bellini, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Diabetic kidney disease (update 2023) : Position paper of the Austrian Diabetes Association and the Austrian Society for Nephrology]Harald Sourij, Roland Edlinger, Friedrich C Prischl, et al.
Ebiomedicine|July 12, 2024
Combination cell therapy leads to clonal deletion of donor-specific T cells in kidney transplant recipientsAna F David, Andreas Heinzel, Michael Kammer, et al.
Transplantation Direct|March 21, 2020
High-activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-specific Antibody-triggered Injury and Renal Allograft SurvivalBlanka Mező, Roman Reindl-Schwaighofer, Farsad Eskandary, et al.
Journal of the American Society of Nephrology : JASN|December 16, 2017
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant RejectionFarsad Eskandary, Heinz Regele, Lukas Baumann, et al.
Wiener Klinische Wochenschrift|May 20, 2026
[Diabetic kidney disease (Update 2026) : Guidelines in a collaboration of the Austrian Diabetes Association and the Austrian Society of Nephrology]Harald Sourij, Felix Aberer, Marlies Antlanger, et al.
Journal of the American Society of Nephrology : JASN|May 13, 2018
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal TransplantationJulio Pascual, Stefan P Berger, Oliver Witzke, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 28, 2026
DARC and Anti-Duffy Antibodies in the Line of Fire: The Challenges in Pinpointing the Etiology of Microcirculation Inflammation to a Distinct EntityFarsad Eskandary, Günther F Körmöczi, Marlies Schönbacher, et al.
Pageof 30

Showing results (251-260 of 291) with videos related to

Sort By:
Pageof 30
Transplantation|April 28, 2016
Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening StudyFarsad Eskandary, Gregor Bond, Nicolas Kozakowski, et al.
Frontiers in Immunology|October 21, 2022
Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipientsBilgin Osmanodja, Johannes Stegbauer, Marta Kantauskaite, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 30, 2021
Organ transplants of the future: planning for innovations including xenotransplantationEmanuele Cozzi, Stefan Schneeberger, Maria Irene Bellini, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Diabetic kidney disease (update 2023) : Position paper of the Austrian Diabetes Association and the Austrian Society for Nephrology]Harald Sourij, Roland Edlinger, Friedrich C Prischl, et al.
Ebiomedicine|July 12, 2024
Combination cell therapy leads to clonal deletion of donor-specific T cells in kidney transplant recipientsAna F David, Andreas Heinzel, Michael Kammer, et al.
Transplantation Direct|March 21, 2020
High-activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-specific Antibody-triggered Injury and Renal Allograft SurvivalBlanka Mező, Roman Reindl-Schwaighofer, Farsad Eskandary, et al.
Journal of the American Society of Nephrology : JASN|December 16, 2017
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant RejectionFarsad Eskandary, Heinz Regele, Lukas Baumann, et al.
Wiener Klinische Wochenschrift|May 20, 2026
[Diabetic kidney disease (Update 2026) : Guidelines in a collaboration of the Austrian Diabetes Association and the Austrian Society of Nephrology]Harald Sourij, Felix Aberer, Marlies Antlanger, et al.
Journal of the American Society of Nephrology : JASN|May 13, 2018
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal TransplantationJulio Pascual, Stefan P Berger, Oliver Witzke, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 28, 2026
DARC and Anti-Duffy Antibodies in the Line of Fire: The Challenges in Pinpointing the Etiology of Microcirculation Inflammation to a Distinct EntityFarsad Eskandary, Günther F Körmöczi, Marlies Schönbacher, et al.
Pageof 30